Bibliography
ACS [Australian Consumers’ Society] [1988] Your Health Rights, Australian Publishing Company, Sydney.
Anspach, R., [1990] “The Language of Case Presentation,” in Sociology of Health and Illness: Critical Perspectives, Conrad, P. and Kern, R., [eds.], St Martin’s Press, New York.
Beardsley, T., [1994] “A War Not Won,” Scientific American, January: 118–126.
Beauchamp, T. and Childress, J., [1989] Principles of Biomedical Ethics, 3rd Edition, Oxford University Press, New York.
Beauchamp, T. and Walters, L., [eds.]. [1982] Contemporary Issues in Bioethics, 2nd Edition., Wadsworth, California.
Braverman, A, [1991] “Viewpoint: Medical Oncology in the 1990s,” The Lancet, 337,13/4:901–2.
Bertero, C. and Ek, A., [1993] “Quality of Life of Adults with Acute Leukaemia,” Journal of Advanced Nursing, 18:1346–1353.
Cassell, E., [1991] The Nature of Suffering and the Goals of Medicine, Oxford University Press, Oxford.
Chabner, B. and Collins, J., [1990] Cancer Chemotherapy, JB Lippincott, New York.
Cilento, R., [1993] Heal Cancer, Hill of Content, Melbourne.
Desai, P., [1994] “Understanding the Biology of Cancer: Has This Any Impact on Treatment?” Journal of Cancer Research and Clinical Oncology, 120:193–199.
Dunstan, G. and Shinebourne, E., [eds.], [1988] Doctors’ Decisions: Ethical Conflicts in Medical Practice, Oxford University Press, Oxford.
Dutton, D., [1988] Worse Than the Disease: Pitfalls of Medical Progress, Cambridge University press, Cambridge.
Faden, R. and Beauchamp, T. [1986] A History and Theory of Informed Consent, Oxford University Press, New York.
Field, D. and James, N., [1993] “Where and How People Die,” in The Future of Palliative Care, Clark, D., [ed.], Open University Press, Buckingham.
Finkler, K., [1991] Physicians at Work, Patients in Pain: Biomedical Practice and Patient Response in Mexico, Westview Press, Oxford.
Fritschi, L. and Taylor, R., [1995] “Cancer — The Major Cause of Premature Mortality in Australia,” Cancer Forum, 19,2:151–155.
Fuchs, V., [1968] “The Growing Demand for Medical Care,” New England Journal of Medicine, 279,4:190–195.
Gelber, R., Goldhirsch, A and Cavalli, F., [1991] “Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer,” Annals of Internal Medicine, 114,8:621–628.
Gerteis, M., [ed.], [1993] Through the patient’s Eyes, Understanding and Promoting Patient-Centered Care, Jossey-Bass Publishers, San Francisco.
Jecker, N., [1991] “Knowing When to Stop: The Limits of Medicine,” Hastings Center Report, May/June:5-8.
Jeffrey, D., [1993] ‘There is Nothing More I Can Do’: An Introduction to the Ethics of Palliative Care, The Pattern Press, Cornwall.
Johnstone, M., [1994] Bioethics: A Nursing Perspective, Harcourt Brace and Company, Marrickville.
Jonsen, A, [1990] The New Medicine and the Old Ethics, Harvard University Press, London.
Kearsley, J., [1989] “Therapeutic Decision-Making in Clinical Oncology: A Matter of Perspective,” Australasian Radiology, 33,1:4–7.
Kearsley, J., [1994] “Wanted: Guidelines for ‘Palliative’ anti-cancer Drug Use,” The Medical Journal of Australia, 160,6/6:723–725.
Markman, M., [1992a] “Partial Responses to Antineoplastic Drug Therapy: What Do They Mean?” Journal of Cancer Research and Clinical Oncology, 119:5–6.
Markman, M., [1992b] “Beyond Palliative Chemotherapy: Providing Hope in an Era of Unrealistic Expectations and Medical-Care Rationing,” Journal of Cancer Research and Clinical Oncology, 119:74–75.
Markman, M., [1992c] “Partial Responses to Antineoplastic Drug Therapy: What Do They Mean?” Journal of Cancer Research and Clinical Oncology, 119:5–6.
Markman, M., [1993a] “Why Does a Higher Response Rate to Chemotherapy Correlate Poorly with Improved Survival?” Journal of Cancer Research and Clinical Oncology, 119:700–701.
Markman, M., [1993b] “Patient Choice, Cost, and Survival of Critically Ill Cancer Patients: A Societal Dilemma,” Journal of Cancer Research and Clinical Oncology, 120:3–4.
Marksman, M., [1994] “The Difficulty Defining ‘Benefit’ of New Antineoplastic Strategies,” Journal of Cancer Research and Clinical Oncology, 120:569–570.
McGrath, P., [1993] “The Implications of the ‘Semiotics of Hope’ in Relation to Chemotherapy,” New Doctor, 60:21–25.
McGrath, P., [1995] “It’s OK to Say No! A Discussion of Ethical Issues Arising From Informed Consent to Chemotherapy,” Cancer Nursing, 18,2:97–103.
McGrath, P. and Kearsley, J., [1995] “Is There a Better Way? Bioethical Reflections on Palliative Cytotoxic Drug Use,” Palliative Medicine, 9:269–271.
McGrath, P. and Turner, G., [1995] “The Ethics of Hope: Newspaper Reporting of Chemotherapy,” Australian Studies in Journalism, 4:50–71.
Mishler, E., [1981] “Viewpoint: Critical Perspectives on the Biomedical Model,” Social Contexts of Health, Illness and Patient Care, Mishler, E., Amarasingham, L., Osherson, S., Hauser, S., Waxler, N.,, Liem, R., [eds.], Cambridge University Press, Cambridge.
Mitchell, K. and Lovat, T., [1991] Bioethics for Medical and Health Professionals, Social Science Press, Wentworth Falls.
Olver, I., Turrell, S., Olszewski, N. and Wilson, K., [1994] “The Impact of a Full Disclosure Information and Consent Form on Patients Receiving Standard Cytotoxic Chemotherapy,” Bioethics 1971–2001, Proceedings for Australian Bioethics Association Third National Conference, 186–200.
Schwartz, R., [1993] “Autonomy, Futility, and the Limits of Medicine,” Bioethics News, 12,3:31–37.
Seffrin, J., Wilson. J. and Black, B., [1991] “Patient Perceptions,” Cancer, March 15, Supplement, 67:1783-1787.
Short, S., [1985] “The War Against Cancer: A Sociological Study of Cancer Treatment,” New Doctor, March,35:25–28.
Singer, P., [1993] “The International Association of Bioethics,” The Medical Journal of Australia, 158:298–299.
Smith, T., Hillner, B. and Desch, C., [1993] “Efficacy and Cost Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis,” Journal of National Cancer Institute, 85,18:1460–1473.
Taussig, M., [1980] “Reification and the Consciousness of the patient,” Social Science and Medicine, 14b:3–13.
Weissman, D., O’Donnell, J. and Brady, A, [1993a] “A Cry From the Fringe,” Journal of Clinical Oncology, [letter], 11:1006.
Weissman, D., O’Donnell, J. and Brady, A, [1993b] “In Reply,” Journal of Clinical Oncology, 11:1837–8.
Young, D., [1991] “An Ethical Approach to Chemotherapy in Private Practice,” Journal of National Cancer Institute, 84,10:810.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGrath, P., Markman, M. Bioethical reflections on the limitations of cytotoxic drug use. Monash Bioethics Review 15, 9–14 (1996). https://doi.org/10.1007/BF03351201
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351201